Bristol-Myers Interest Coverage Trend from 2010 to 2021

BMY -  USA Stock  

USD 66.47  0.30  0.45%

Bristol-Myers Squibb Interest Coverage yearly trend continues to be fairly stable with very little volatility. Interest Coverage is likely to outpace its year average in 2021. During the period from 2010 to 2021, Bristol-Myers Squibb Interest Coverage regression line of anual values had r-squared of 0.45 and arithmetic mean of  31.46. Bristol-Myers Squibb Direct Expenses is fairly stable at the moment as compared to the past year. Bristol-Myers Squibb reported Direct Expenses of 11.77 Billion in 2020. Net Income to Non Controlling Interests is likely to rise to about 20.5 M in 2021, whereas Consolidated Income is likely to drop (9.2 B) in 2021.

Search Historical Trends 

 
Refresh
Check Bristol-Myers Squibb financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol-Myers main balance sheet or income statement drivers, such as Direct Expenses of 12.7 B, Cost of Revenue of 9.6 B or Gross Profit of 25.3 B, as well as many exotic indicators such as Interest Coverage of 10.64, Long Term Debt to Equity of 1.38 or Calculated Tax Rate of 24.75. Bristol-Myers financial statements analysis is a perfect complement when working with Bristol-Myers Squibb Valuation or Volatility modules. It can also supplement various Bristol-Myers Squibb Technical models. Continue to the analysis of Bristol-Myers Squibb Correlation against competitors.

Bristol-Myers Interest Coverage Breakdown

Showing smoothed Interest Coverage of Bristol-Myers Squibb with missing and latest data points interpolated. Bristol-Myers Squibb's Interest Coverage historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol-Myers Squibb's overall financial position and show how it may be relating to other accounts over time.
Interest Coverage10 Years Trend
Decreasing
Slightly volatile
 Interest Coverage 
Share
      Timeline 

Bristol-Myers Interest Coverage Regression Statistics

Arithmetic Mean 31.46
Geometric Mean 21.31
Coefficient Of Variation 110.98
Mean Deviation 23.68
Median 18.43
Standard Deviation 34.91
Sample Variance 1,219
Range 111.93
R-Value(0.67)
Mean Square Error 741.44
R-Squared 0.45
Significance 0.017466
Slope(6.47)
Total Sum of Squares 13,406

Bristol-Myers Interest Coverage History

2011  120.94 
2012  29.74 
2013  15.56 
2014  12.76 
2015  10.27 
2016  27.72 
2017  18.43 
2018  27.97 
2019  9.01 
2020  10.37 
2021  10.64 

About Bristol-Myers Squibb Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bristol-Myers Squibb income statement, its balance sheet, and the statement of cash flows. Bristol-Myers Squibb investors use historical funamental indicators, such as Bristol-Myers Squibb's Interest Coverage, to determine how well the company is positioned to perform in the future. Although Bristol-Myers Squibb investors may use each financial statement separately, they are all related. The changes in Bristol-Myers Squibb's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bristol-Myers Squibb's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bristol-Myers Squibb Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bristol-Myers Squibb. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Interest Coverage 10.37  10.64 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA3.5 B4.6 B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 30250 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bristol-Myers Squibb without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Pair Trading with Bristol-Myers Squibb

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol-Myers Squibb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will appreciate offsetting losses from the drop in the long position's value.

Bristol-Myers Squibb Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bristol-Myers Squibb and Grifols SA. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Bristol-Myers Squibb Correlation against competitors. Note that the Bristol-Myers Squibb information on this page should be used as a complementary analysis to other Bristol-Myers Squibb's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Bristol-Myers Squibb Stock analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol-Myers that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol-Myers Squibb's value that differs from its market value or its book value, called intrinsic value, which is Bristol-Myers Squibb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol-Myers Squibb's market value can be influenced by many factors that don't directly affect Bristol-Myers Squibb underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.